FDA Puts The Kibosh On Distracting Drug Ads

Law360, New York (May 26, 2009, 12:00 AM EDT) -- The U.S. Food and Drug Administration issued proposed guidelines Wednesday for prescription drug and medical device advertisements, advising pharmaceutical companies to stay away from discordant visuals and distracting music in TV ads, among a slew of other recommendations.

The draft guidance comes in response to requests the FDA has received for specific details on what the agency looks for when evaluating advertisements and promotional labeling for medications and medical devices, the agency said. Some 60 percent of patients do not believe drug marketing materials provide enough...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.